Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Merck KGaA
  6. News
  7. Most relevant
    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about MERCK KGAA
10/14MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German Securities..
EQ
10/14MERCK : EMD Serono, Inc. - New Real-World MAVENCLAD Data Show Sustained Effectiveness and ..
AQ
10/13Merck KGaA's Multiple Sclerosis Treatment Drug Shows Improved Quality Of Life In Study
MT
10/13MERCK KGAA : JP Morgan reaffirms its Buy rating
MD
10/12MERCK : Opens Second Facility In California, US, With $115 Million Investment
MT
10/12MERCK KGAA : Bernstein reiterates its Neutral rating
MD
10/12MERCK : MilliporeSigma Announces Completion of New Viral Vector Contract Development Manuf..
AQ
10/07MERCK KGAA : Gets a Neutral rating from NorldLB
MD
10/06MARKETMIND : Hunker down, it's going to be one of those days
RE
10/05CORRECTION : Merck KGaA Agrees to License CRISPR Technology to Genomics Group Cellecta
MT
10/05MERCK : Licenses CRISPR Technology To Genome Group Cellecta
MT
10/04MARKETMIND : Emerging Britain
RE
10/04MERCK : Completes Enrollment In Late-Stage Multiple Sclerosis Drug Trial
MT
10/04MERCK : UK Reviewing COVID-19 Drug Options, Including Merck's Molnupiravir
MT
10/01MARKETMIND : Final Quarter Blues
RE
10/01UK midcaps end at two-month lows in dour start to new quarter
RE
09/30ADRs Close Mostly Lower; AstraZeneca, Diageo Trade Actively
DJ
09/30GLAXOSMITHKLINE : Merck KGaA, GlaxoSmithKline Terminate Agreement to Develop Bintrafusp Al..
MT
09/30MERCK : GSK end partnership on former cancer drug hopeful
RE
09/30MERCK : Mutually Terminates Agreement On Cancer Drug With GSK
MT
09/30Correction to Merck, GlaxoSmithKline Article
DJ
09/30Merck KGaA, GlaxoSmithKline Terminate Agreement on Cancer Drug Development
DJ
09/29MERCK : Interim Chief Information Officer Takes On Permanent Role
MT
09/29MARKETMIND : When it rains, it pours
RE
09/28MARKETMIND : Time to expect inflation
RE
09/28Artios Doses First Patient in Phase 1/2a Study of Pol? Inhibitor ART4215
DJ
09/27MERCK : CIRCA GROUP'S BIO-BASED CHEMICALS FEATURED IN MERCK KGaA WEBINAR
AQ
09/24Merck KGaA english
DJ
09/24MARKETMIND : Move over Evergrande, time to watch soaring bond yields
RE
09/23MARKETMIND : E-Day and central banks galore
RE
09/22MERCK : Names Head of Newly-Created Group Communications, Brand and Corporate Affairs Divi..
MT
09/22MARKETMIND : Some relief - but how long will it last?
RE
09/21Nektar Therapeutics Shares Rise 5% on Deal With Pfizer, Merck KGaA
DJ
09/21NEKTAR THERAPEUTICS : Partners With Pfizer, Merck for Clinical Trial
MT
09/21MERCK KGAA : Berenberg remains Neutral
MD
09/21MERCK : Opens $33 Million Production Line For Silica-based Effect Pigments In Germany
MT
09/21MERCK KGAA : Goldman Sachs keeps a Sell rating
MD
09/21MERCK KGAA : Buy rating from Deutsche Bank
MD
09/21MARKETMIND : Losing the plot
RE
09/20EUROPEAN MIDDAY BRIEFING : Stocks Slump on China Fears
DJ
09/20MERCK : Plans Over $3.5 Billion Investment By 2025 To Grow Electronics Business Sector
MT
09/20Merck KGaA to Invest More Than $3.5 Billion in Electronics Business
DJ
09/20MARKETMIND : Watch those spiralling gas prices
RE
09/17MERCK : Agilyx AS (AGLX) - MilliporeSigma Joins Cyclyx as Founding Member
AQ
09/17MERCK KGAA : Morgan Stanley remains Neutral
MD
09/17MERCK : Trade Limitations Force Vaccine Producers To Rethink Supply Chain
MT
09/17MARKETMIND : Evergrande worries? Not really
RE
09/16MERCK KGAA : Release according to -4-
DJ
09/16MERCK KGAA : Release according to -3-
DJ
09/16MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German Securities..
DJ
09/16MERCK KGAA : Release according to -2-
DJ
09/14MERCK KGAA : Release according to -3-
DJ
09/14MERCK KGAA : Release according to -4-
DJ
09/14MERCK KGAA : Release according to -2-
DJ
09/14MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German Securities..
DJ
09/14MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German Securities..
EQ
09/14MERCK : Group CFO Presentation
PU
09/14ANALYST RECOMMENDATIONS : Apple, Bank of America, Cisco, DT Midstream, Halliburton...
09/14MARKETMIND : Pandeconomics part 2
RE
09/14MERCK KGAA : UBS gives a Sell rating
MD
09/13MERCK KGAA : DZ Bank reiterates its Neutral rating
MD
09/13MARKETMIND : September setback
RE
09/13MERCK KGAA : Deutsche Bank gives a Buy rating
MD
09/13MERCK KGAA : Barclays reiterates its Neutral rating
MD
09/10MERCK KGAA : Gets a Neutral rating from NorldLB
MD
09/10MERCK KGAA : Deutsche Bank remains its Buy rating
MD
09/10MERCK KGAA : Credit Suisse gives a Buy rating
MD
09/10MERCK KGAA : Berenberg reiterates its Neutral rating
MD
09/10MARKETMIND : Hitting the buffers
RE
09/10MERCK KGAA : Gets a Buy rating from JP Morgan
MD
09/09EUROPEAN MIDDAY BRIEFING : Stocks Under Pressure Ahead of ECB
DJ
09/09MERCK KGAA : UBS reaffirms its Neutral rating
MD
09/09MERCK KGAA : Gets a Buy rating from JP Morgan
MD
09/09MERCK : says lab supplies business can grow by up to 10% per year
RE
09/09Merck to Seek M&A
CI
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on MERCK KGAA
11/11/21